​

Cyclacel Pharmaceuticals (CYCC) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CYCC Stock Forecast

Cyclacel Pharmaceuticals (CYCC) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $1.00, with a high of $1.00 and a low of $1.00. This represents a 177.78% increase from the last price of $0.36.

High: $1 Avg: $1 Low: $1 Last Closed Price: $0.36

CYCC Stock Rating

Cyclacel Pharmaceuticals stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (83.33%), 1 Hold (16.67%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 1 5 0 Strong Sell Sell Hold Buy Strong Buy

CYCC Price Target Upside V Benchmarks

TypeNameUpside
StockCyclacel Pharmaceuticals177.78%
SectorHealthcare Stocks 23.68%
IndustryBiotech Stocks 64.77%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$1.00
Last Closing Price$0.36$0.36$0.36
Upside/Downside--177.78%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 25--1--1
Jan, 25--1--1
Dec, 24--1--1
Nov, 24-11--2
Oct, 24111--3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 23, 2024Jonathan AschoffRoth Capital$1.00$1.14-12.28%177.78%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 07, 2023OppenheimerOutperformOutperformhold

Financial Forecast

EPS Forecast

$-30 $-22 $-14 $-6 $2 $10 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-26.75$-2.09----
Avg Forecast$-20.23$-1.95$-1.18$-1.12$3.67$5.49
High Forecast$-19.70$-1.95$-1.18$-1.12$3.67$5.49
Low Forecast$-20.75$-1.95$-1.18$-1.12$3.67$5.49
Surprise %32.23%7.18%----

Revenue Forecast

$0 $30M $60M $90M $120M $150M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$420.00K$43.00K----
Avg Forecast$263.00K$53.00K$100.00K$100.00K$80.58M$118.08M
High Forecast$263.00K$53.00K$100.00K$100.00K$80.58M$118.08M
Low Forecast$263.00K$53.00K$100.00K$100.00K$80.58M$118.08M
Surprise %59.70%-18.87%----

Net Income Forecast

$-25M $-19M $-13M $-7M $-1M $5M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-22.55M$-11.21M----
Avg Forecast$-17.21M$-1.66M$-1.00M$-952.91K$3.12M$4.67M
High Forecast$-16.76M$-1.66M$-1.00M$-952.91K$3.12M$4.67M
Low Forecast$-17.65M$-1.66M$-1.00M$-952.91K$3.12M$4.67M
Surprise %31.09%575.79%----

CYCC Forecast FAQ

Is Cyclacel Pharmaceuticals stock a buy?

Cyclacel Pharmaceuticals stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Cyclacel Pharmaceuticals is a favorable investment for most analysts.

What is Cyclacel Pharmaceuticals's price target?

Cyclacel Pharmaceuticals's price target, set by 6 Wall Street analysts, averages $1 over the next 12 months. The price target range spans from $1 at the low end to $1 at the high end, suggesting a potential 177.78% change from the previous closing price of $0.36.

How does Cyclacel Pharmaceuticals stock forecast compare to its benchmarks?

Cyclacel Pharmaceuticals's stock forecast shows a 177.78% upside, outperforming the average forecast for the healthcare stocks sector (23.68%) and outperforming the biotech stocks industry (64.77%).

What is the breakdown of analyst ratings for Cyclacel Pharmaceuticals over the past three months?

  • February 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • January 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.

What is Cyclacel Pharmaceuticals’s EPS forecast?

Cyclacel Pharmaceuticals's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.18, marking a -43.54% decrease from the reported $-2.09 in 2024. Estimates for the following years are $-1.12 in 2026, $3.67 in 2027, and $5.49 in 2028.

What is Cyclacel Pharmaceuticals’s revenue forecast?

Cyclacel Pharmaceuticals's average annual revenue forecast for its fiscal year ending in December 2025 is $100K, reflecting a 132.56% increase from the reported $43K in 2024. The forecast for 2026 is $100K, followed by $80.58M for 2027, and $118.08M for 2028.

What is Cyclacel Pharmaceuticals’s net income forecast?

Cyclacel Pharmaceuticals's net income forecast for the fiscal year ending in December 2025 stands at $-1.004M, representing a -91.05% decrease from the reported $-11.212M in 2024. Projections indicate $-953K in 2026, $3.12M in 2027, and $4.67M in 2028.